QUADRANT LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Quadrant 4 System Corp. To Contact The Firm

Jul 26, 2017 20:49 pm UTC| Business

NEW YORK, July 26, 2017 -- Faruqi Faruqi, LLP, a leading national securities law firm, reminds investors in Quadrant 4 System Corp. (“Quadrant” or the “Company”) (OTC:QFOR) of the September 5, 2017 deadline to seek the...

Crown Castle Closes Public Offerings of Common Stock and Mandatory Convertible Preferred Stock

Jul 26, 2017 20:45 pm UTC| Business

HOUSTON, July 26, 2017 -- Crown Castle International Corp. (NYSE:CCI) ("Crown Castle") announced today that it has closed its concurrent offerings of 40,150,000 shares of its common stock at $96.00 per share and...

Churchill Downs Incorporated Appoints Douglas C. Grissom as New Board Member

Jul 26, 2017 20:35 pm UTC| Business

LOUISVILLE, Ky., July 26, 2017 -- Churchill Downs Incorporated (NASDAQ:CHDN) (CDI or the Company) announced today that Douglas C. Grissom, a Managing Director for Madison Dearborn Partners, LLC, was appointed as a Class...

Tetraphase Announces Proposed Public Offering of Common Stock

Jul 26, 2017 20:31 pm UTC| Business

WATERTOWN, Mass., July 26, 2017 -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections,...

Marathon Oil Corporation Declares Second Quarter 2017 Dividend

Jul 26, 2017 20:30 pm UTC| Business

HOUSTON, July 26, 2017 -- Marathon Oil Corporation (NYSE: MRO) announced today that the Company's board of directors has declared a dividend of 5 cents per share on Marathon Oil Corporation common stock. The dividend is...

ESSA Bancorp, Inc. Reports Fiscal 2017 Third Quarter, Nine Month Financial Results

Jul 26, 2017 20:30 pm UTC| Business

STROUDSBURG, Pa., July 26, 2017 -- ESSA Bancorp, Inc. (the “Company”) (NASDAQ:ESSA) today reported net income of $1.8 million, or $0.16 per diluted share, for the quarter ended June 30, 2017, compared with net income of...

Esperion Announces Initiation of Phase 2 Study of Bempedoic Acid Added-On to a PCSK9 Inhibitor

Jul 26, 2017 20:30 pm UTC| Business

ANN ARBOR, Mich., July 26, 2017 -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies...